Skip to main content
Journal ArticleOPEN ACCESS

Metformin Is Associated With Survival Benefit in Cancer Patients With Concurrent Type 2 Diabetes: A Systematic Review and Meta-Analysis

  • Yin M
  • Zhou J
  • Gorak E
  • et al.
The Oncologist (2013) 18(12) 1248-1255
DOI: 10.1634/theoncologist.2013-0111
144Citations
Citations of this article
108Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Describe the influences of different types of glucose-lowering medications on therapeutic outcomes of cancer patients who received standard anticancer treatment. Compare the survival associated with metformin treatment with survival in treatment with other glucose-lowering medications.

References Powered by Scopus

Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis

Biometrics
10882Citations
N/AReaders
Get full text

Practical methods for incorporating summary time-to-event data into meta-analysis

Trials
5120Citations
N/AReaders
Get full text

Diabetes and cancer: A consensus report

Diabetes Care
1655Citations
N/AReaders
Get full text
View more at Scopus

Cited by Powered by Scopus

Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis

Annals of Oncology
344Citations
N/AReaders
Get full text

Cellular senescence in type 2 diabetes: A therapeutic opportunity

Diabetes
319Citations
N/AReaders
Get full text

Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma

Journal of Clinical Oncology
241Citations
N/AReaders
Get full text
View more at Scopus

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Yin, M., Zhou, J., Gorak, E. J., & Quddus, F. (2013). Metformin Is Associated With Survival Benefit in Cancer Patients With Concurrent Type 2 Diabetes: A Systematic Review and Meta-Analysis. The Oncologist, 18(12), 1248–1255. https://doi.org/10.1634/theoncologist.2013-0111

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 28

53%

Researcher 17

32%

Professor / Associate Prof. 4

8%

Lecturer / Post doc 4

8%

Readers' Discipline

Tooltip

Medicine and Dentistry 25

60%

Biochemistry, Genetics and Molecular Bi... 9

21%

Agricultural and Biological Sciences 5

12%

Pharmacology, Toxicology and Pharmaceut... 3

7%

Save time finding and organizing research with Mendeley

Sign up for free